Jordan Paradise

Loyola University Chicago School of Law

25 E. Pearson

Chicago, IL 60611

United States

  • Loyola University Chicago School of Law

SCHOLARLY PAPERS

38

DOWNLOADS
Rank 12,065

SSRN RANKINGS

Top 12,065

in Total Papers Downloads

4,753

SSRN CITATIONS
Rank 17,962

SSRN RANKINGS

Top 17,962

in Total Papers Citations

6

CROSSREF CITATIONS

52

Scholarly Papers (38)

Actions:
Email selected abstracts
1.

European Opposition to Exclusive Control Over Predictive Breast Cancer Testing and the Inherent Implications for United States Patent Law and Public Policy: A Case Study of the Myriad Genetics' Brca Patent Controversy

Food & Drug Law Journal, Vol. 59, No. 1, 2004
Number of pages: 23 Posted: 24 Apr 2006
Jordan Paradise
Loyola University Chicago School of Law
Downloads 774 (37,933)

Abstract:

Loading...

intellectual property law, breast cancer, patent, European Patent Office, opposition, health care, research

2.

Gene Patents: The Need for Bioethics Scrutiny and Legal Change

Yale Journal of Health, Policy, Law and Ethics, Vol. 5, 2005
Number of pages: 10 Posted: 24 Apr 2006
Jordan Paradise and Lori Andrews
Loyola University Chicago School of Law and Chicago-Kent College of Law
Downloads 354 (101,129)

Abstract:

Loading...

gene patent, health care, research

3.

No Sisyphean Task: How the FDA Can Regulate Electronic Cigarettes

XIII Yale Journal of Health Policy, Law, and Ethics 1-32 (Spring 2013).
Number of pages: 32 Posted: 28 Jul 2012 Last Revised: 17 Jul 2013
Jordan Paradise
Loyola University Chicago School of Law
Downloads 345 (103,683)

Abstract:

Loading...

electronic cigarettes, FDA, Family Smoking Prevention and Tobacco Control Act, marketing, promotion, safety

4.

U.S. Regulatory Challenges for Gene Editing

Number of pages: 8 Posted: 29 Jul 2016
Jordan Paradise
Loyola University Chicago School of Law
Downloads 231 (157,437)

Abstract:

Loading...

Gene editing, regulation, FDA

5.

Exploring Emerging Nanobiotechnology Drugs and Medical Devices

Food & Drug Law Journal, Vol. 63, No. 2, pp. 407-420, 2008
Number of pages: 15 Posted: 05 Jun 2008
Jordan Paradise, Gail Diliberto, Alison Tisdale and Efrosini Kokkoli PhD
Loyola University Chicago School of Law, University of Minnesota - Twin Cities - Dept of Sociology, University of Minnesota - Twin Cities - Dept of Sociology and University of Minnesota, Twin Cities
Downloads 206 (175,484)

Abstract:

Loading...

nanotechnology, FDA, drugs, medical devices, combination products, regulation

6.

The Legal and Regulatory Status of Biosimilars: How Product Naming and State Substitution Laws May Impact the U.S. Healthcare System

41 American Journal of Law and Medicine 49 (2015).
Number of pages: 36 Posted: 27 Jan 2015 Last Revised: 28 Jul 2016
Jordan Paradise
Loyola University Chicago School of Law
Downloads 193 (186,261)

Abstract:

Loading...

biosimilars, biologics, FDA, naming, substitution, health care, Biologics Price Competition and Innovation Act, Affordable Care Act

7.

REMS as a Competitive Tactic: Is Big Pharma Hijacking Drug Access and Patient Safety?

15 Houston Journal of Health Law and Policy 43 (2015).
Number of pages: 40 Posted: 27 Jan 2015 Last Revised: 23 Oct 2015
Jordan Paradise
Loyola University Chicago School of Law
Downloads 164 (214,646)
Citation 1

Abstract:

Loading...

FDA, risk evaluation and mitigation strategies, REMS, anticompetitive, labeling, postmarket, generic drugs, drug approval

8.

The Devil is in the Details: Health Care Reform, Biosimilars, and Implementation Challenges for the Food and Drug Administration

Jurimetrics Journal, Vol. 51, pp. 279–292, 2011
Number of pages: 14 Posted: 26 May 2011 Last Revised: 28 Jul 2013
Jordan Paradise
Loyola University Chicago School of Law
Downloads 154 (226,357)

Abstract:

Loading...

Biologics, Food and Drug Administration, biosimilars, Patient Protection and Affordable Care Act

9.

Recommendations for Oversight of Nanobiotechnology: Dynamic Oversight for Complex and Convergent Technology

Journal of Nanoparticle Research, Vol. 13, pp. 1345-1371, 2011
Number of pages: 47 Posted: 23 Jan 2011 Last Revised: 28 Jul 2013
Gurumurthy Ramachandran PhD, Susan M. Wolf, Jordan Paradise, Jennifer Kuzma, Ralph Hall JD, Efrosini Kokkoli PhD and Leili Fatehi JD
University of Minnesota, Twin Cities, University of Minnesota Law School, Loyola University Chicago School of Law, University of Minnesota, Twin Cities - Hubert H. Humphrey Institute of Public Affairs, University of Minnesota, Twin Cities - School of Law, University of Minnesota, Twin Cities and University of Minnesota - Twin Cities - Hubert H. Humphrey Institute of Public Affairs
Downloads 141 (243,155)

Abstract:

Loading...

Science Oversight, Technology Oversight, Dynamic Oversight, New Governance, Science Regulation, Technology Regulation, Nanotechnology, Nanobiotechnology, NNI, FDA, EPA, OSHA, NIOSH, NIH, OSTP, Law and Science, Bioethics

10.

Developing Oversight Frameworks for Nanobiotechnology

Minnesota Journal of Law, Science & Technology, Vol. 9, No. 1, pp. 187-203, 2008
Number of pages: 17 Posted: 09 Mar 2008 Last Revised: 18 Nov 2014
Jordan Paradise, Susan M. Wolf, Gurumurthy Ramachandran PhD, Efrosini Kokkoli PhD, Ralph Hall JD and Jennifer Kuzma
Loyola University Chicago School of Law, University of Minnesota Law School, University of Minnesota, Twin Cities, University of Minnesota, Twin Cities, University of Minnesota, Twin Cities - School of Law and University of Minnesota, Twin Cities - Hubert H. Humphrey Institute of Public Affairs
Downloads 140 (244,560)

Abstract:

Loading...

nanotechnology, regulation, oversight, federal agencies

11.

Lessons from the European Union: The Need for a Post-Grant Mechanism for Third-Party Challenge to U.S. Patents

Minnesota Journal of Law, Science & Technology, Vol. 7, No. 1, pp. 315-326, 2005, Minnesota Legal Studies Research Paper No. 06-22
Number of pages: 12 Posted: 27 Apr 2006
Jordan Paradise
Loyola University Chicago School of Law
Downloads 140 (244,560)

Abstract:

Loading...

BRCA, patents, genetics research, health care, European Union, opposition

12.

Synthetic Biology: Does Re-Writing Nature Require Re-Writing Regulation?

117 Penn St. L. Rev. 53 (2012).
Number of pages: 36 Posted: 20 Dec 2011 Last Revised: 18 Apr 2013
Jordan Paradise and Ethan Fitzpatrick
Loyola University Chicago School of Law and Seton Hall University - School of Law
Downloads 136 (250,351)
Citation 1

Abstract:

Loading...

synthetic biology, FDA, safety, medical products

13.

Follow-On Biologics: Implementation Challenges and Opportunities

Seton Hall Law Review, Vol. 41, p. 501, 2011
Number of pages: 10 Posted: 26 May 2011
Jordan Paradise
Loyola University Chicago School of Law
Downloads 133 (254,706)

Abstract:

Loading...

Biologics, FDA, Biologics Price Competition and Affordable Care Act

14.

Genetic Sequence Patents: Historical Justification and Current Impacts

Max Planck Conference, Living Properties: Making Knowledge and Controlling Ownership in the History of Biology, pp. 137-164, 2009
Number of pages: 46 Posted: 30 Jun 2010
Lori Andrews and Jordan Paradise
Chicago-Kent College of Law and Loyola University Chicago School of Law
Downloads 131 (257,640)

Abstract:

Loading...

gene patents, products of nature, process, USPTO, case law

15.

Reassessing Safety for Nanotechnology Combination Products: What Do 'Biosimilars' Add to Regulatory Challenges for the FDA?

Jordan Paradise, Reassessing Safety for Nanotechnology Combination Products: What Do Biosimilars Add to Regulatory Challenges for the FDA?, 56 St. Louis U. L. J. 465 (2012)., Saint Louis U. Legal Studies Research Paper
Number of pages: 56 Posted: 29 May 2011 Last Revised: 09 Jan 2014
Jordan Paradise
Loyola University Chicago School of Law
Downloads 129 (260,633)

Abstract:

Loading...

nanotechnology, Food and Drug Administration, drugs, devices, biologics, health care reform

16.

A Profile of Bio-Pharma Consolidation Activity

Annals of Health Law, Vol. 25, No. 2, 2016
Number of pages: 28 Posted: 29 Jul 2016 Last Revised: 28 Feb 2018
Jordan Paradise
Loyola University Chicago School of Law
Downloads 117 (280,138)

Abstract:

Loading...

pharmaceuticals, generic drugs, prescription drugs, mergers, consolidation, Federal Trade Commission, drug prices, antitrust

17.

Tales from the Crypt: Scientific, Ethical, and Legal Considerations for Biohistorical Analysis of Deceased Historical Figures

Temple Journal of Science, Technology & Environmental Law, Vol. 26, pp. 223-299, 2007
Number of pages: 77 Posted: 10 Jan 2008
Jordan Paradise and Lori Andrews
Loyola University Chicago School of Law and Chicago-Kent College of Law
Downloads 117 (280,138)

Abstract:

Loading...

genetics research, biohistory, historical figures

18.

Managing Incidental Findings in Human Subjects Research: Analysis and Recommendations

Journal of Law, Medicine and Ethics, Vol. 36, No. 2, pp. 219-248, 2008
Number of pages: 30 Posted: 08 Dec 2010 Last Revised: 06 Feb 2014
Susan M. Wolf, Frances P. Lawrenz PhD, Charles A. Nelson, Jeffrey P. Kahn, Mildred K. Cho, Ellen Wright Clayton, Joel G. Fletcher, Michael K. Georgieff, Dale Hammerschmidt, Kathy Hudson, Judy Illes, Vivek Kapur, Moira Keane M.A., Barbara Koenig, Bonnie LeRoy, Elizabeth McFarland, Jordan Paradise, Lisa Parker, Sharon Terry, Brian Van Ness and Benjamin Wilfond
University of Minnesota Law School, University of Minnesota - Twin Cities, Harvard University - Department of Pediatrics, Johns Hopkins Berman Institute of Bioethics, Stanford University - Stanford Center for Biomedical Ethics (SCBE), Vanderbilt University - Law School, Mayo Clinic - College of Medicine, University of Minnesota - Twin Cities, University of Minnesota - Twin Cities, Government of the United States of America - National Institutes of Health (NIH), University of British Columbia (UBC), Pennsylvania State University, University of Minnesota - Twin Cities, University of California, San Francisco (UCSF), University of Minnesota - Twin Cities, St. Luke's Hospital, Loyola University Chicago School of Law, University of Pittsburgh, Genetic Alliance, University of Minnesota - Twin Cities and University of Washington
Downloads 115 (283,608)
Citation 2

Abstract:

Loading...

incidental findings, human subjects research, bioethics, health law

19.

Patents on Human Genes: An Analysis of Scope and Claims

Science, Vol. 307, 2005
Number of pages: 2 Posted: 24 Apr 2006 Last Revised: 16 Aug 2017
Jordan Paradise, Lori Andrews and Timothy R. Holbrook
Loyola University Chicago School of Law, Chicago-Kent College of Law and Emory University
Downloads 107 (298,312)
Citation 1

Abstract:

Loading...

United States Patent & Trademark Office, patent, claim, gene

20.

Claiming Nanotechnology: Improving USPTO Efforts at Classification of Emerging Nano-Enabled Pharmaceutical Technologies

Northwestern Journal of Technology and Intellectual Property, Vol. 10, No. 3, pp. 169-207, 2012
Number of pages: 42 Posted: 27 Oct 2011 Last Revised: 22 Feb 2014
Jordan Paradise
Loyola University Chicago School of Law
Downloads 95 (322,653)

Abstract:

Loading...

USPTO, nanotechnology, patents, pharmaceuticals, drugs, claims, classification, science and law, technology and law, intellectual property law, federal agencies

21.

The Challenge of Developing Oversight Approaches to Nanobiotechnology

Downloads 89 (336,140)

The Challenge of Developing Oversight Approaches to Nanobiotechnology

Journal of Law, Medicine & Ethics, Vol. 37, pp. 543-545, 2009
Number of pages: 3 Posted: 01 Jul 2010 Last Revised: 27 Apr 2012
Jordan Paradise, Susan M. Wolf, Jennifer Kuzma, Gurumurthy Ramachandran PhD and Efrosini Kokkoli PhD
Loyola University Chicago School of Law, University of Minnesota Law School, University of Minnesota, Twin Cities - Hubert H. Humphrey Institute of Public Affairs, University of Minnesota, Twin Cities and University of Minnesota, Twin Cities
Downloads 52 (454,597)

Abstract:

Loading...

nanotechnology, nanobiotechnology, United States, oversight, law

The Challenge of Developing Oversight Approaches to Nanobiotechnology

Journal of Law, Medicine and Ethics, Vol. 37, No. 4, p. 535, Winter 2009
Number of pages: 8 Posted: 06 Jan 2011
Susan M. Wolf, Gurumurthy Ramachandran PhD, Jennifer Kuzma and Jordan Paradise
University of Minnesota Law School, University of Minnesota, Twin Cities, University of Minnesota, Twin Cities - Hubert H. Humphrey Institute of Public Affairs and Loyola University Chicago School of Law
Downloads 37 (522,512)

Abstract:

Loading...

nanotechnology, nanobiotechnology, law and science, technology oversight, science oversight, regulation of science and technology, emerging technologies, law and empirical studies. FDA, EPA, OSHA, NIOSH, NIH, RAC, USDA, NNI

22.

Developing U.S. Oversight Strategies for Nanobiotechnology: Learning from Past Oversight Experiences

Journal of Law, Medicine & Ethics, Vol. 37, No. 4, pp. 688-705, Winter 2009
Number of pages: 18 Posted: 30 Jun 2010 Last Revised: 18 Nov 2014
Jordan Paradise, Susan M. Wolf, Jennifer Kuzma, Aliya Kuzhabekova, Alison Tisdale, Efrosini Kokkoli PhD and Gurumurthy Ramachandran PhD
Loyola University Chicago School of Law, University of Minnesota Law School, University of Minnesota, Twin Cities - Hubert H. Humphrey Institute of Public Affairs, University of Minnesota - Twin Cities, University of Minnesota - Twin Cities - Dept of Sociology, University of Minnesota, Twin Cities and University of Minnesota, Twin Cities
Downloads 89 (336,140)

Abstract:

Loading...

23.

The Law of Incidental Findings in Human Subjects Research: Establishing Researchers' Duties

Journal of Law, Medicine & Ethics, Vol. 36, No. 2, pp. 361-383, 2008
Number of pages: 23 Posted: 30 Jun 2010 Last Revised: 25 Dec 2010
Susan M. Wolf, Jordan Paradise and Charlisse Caga Anan
University of Minnesota Law School, Loyola University Chicago School of Law and Cleveland Clinic - Department of Bioethics
Downloads 83 (350,773)

Abstract:

Loading...

incidental findings, genetics, research, informed consent, disclosure of results, law, ethics

24.

21st Century Citizen Pharma: The FDA & Patient-Focused Product Development

44 American Journal of Law and Medicine 309 (2018)
Number of pages: 20 Posted: 07 Mar 2018 Last Revised: 27 Jan 2021
Jordan Paradise
Loyola University Chicago School of Law
Downloads 77 (366,505)

Abstract:

Loading...

Patient Advocacy, 21st Century Cures Act, FDA, Drugs, Devices, Biologics

25.

Evaluating Oversight of Human Drugs and Medical Devices: A Case Study of the FDA and Implications for Nanobiotechnology

Journal of Law, Medicine & Ethics, Vol. 37, No. 4, pp. 598-624, Winter 2009
Number of pages: 27 Posted: 30 Jun 2010
Jordan Paradise, Alison Tisdale, Ralph Hall JD and Efrosini Kokkoli PhD
Loyola University Chicago School of Law, University of Minnesota - Twin Cities - Dept of Sociology, University of Minnesota, Twin Cities - School of Law and University of Minnesota, Twin Cities
Downloads 66 (398,778)

Abstract:

Loading...

Food and Drug Administration, nanotechnology, nanobiotechnology, drugs, medical devices, oversight

26.

Nanobiotechnology and the Food and Drug Administration

Food and Drug Law Institute Update, pp. 23-35, March/April 2010
Number of pages: 3 Posted: 30 Jun 2010
Jordan Paradise
Loyola University Chicago School of Law
Downloads 62 (411,833)

Abstract:

Loading...

27.

An Integrated Approach to Oversight Assessment for Emerging Technologies

Risk Analysis, Vol. 28, No. 5, pp. 1197-1219, 2008
Number of pages: 23 Posted: 16 Jan 2011 Last Revised: 22 Jan 2011
Jennifer Kuzma, Jordan Paradise, Gurumurthy Ramachandran PhD, Jee-Ae Kim, Adam Kokotovich and Susan M. Wolf
University of Minnesota, Twin Cities - Hubert H. Humphrey Institute of Public Affairs, Loyola University Chicago School of Law, University of Minnesota, Twin Cities, University of Minnesota - Twin Cities, University of Minnesota - Twin Cities and University of Minnesota Law School
Downloads 57 (428,968)

Abstract:

Loading...

Nanotechnology, nanobiotechnology, science and technology, emerging technology, oversight, oversight systems, empirical studies, expert elicitation, multi-criteria assessment, risk analysis, science regulation, oversight assessment, new governance, gene therapy, biotechnology, GMOs

28.

Cultivating Innovation in Precision Medicine Through Regulatory Flexibility at the FDA

NYU Journal of Law & Liberty, Vol. 11, No. 672, 2017
Number of pages: 40 Posted: 14 Feb 2017 Last Revised: 28 Feb 2018
Jordan Paradise
Loyola University Chicago School of Law
Downloads 56 (432,510)

Abstract:

Loading...

Precision medicine, companion diagnostics, drugs, medical devices, FDA, regulation, 21st Century Cures Act, innovation

29.

Exploring Precision FDA, an Online Platform for Crowdsourcing Genomics

Jordan Paradise, Exploring Precision FDA, an Online Platform for Crowdsourcing Genomics, 58 Jurimetrics 1 (2018).
Number of pages: 16 Posted: 14 Aug 2017 Last Revised: 11 Feb 2020
Jordan Paradise
Loyola University Chicago School of Law
Downloads 53 (443,438)
Citation 2

Abstract:

Loading...

30.

Public Health Preparedness & Response: An Exercise in Administrative Law

Downloads 40 (497,084)

Public Health Preparedness & Response: An Exercise in Administrative Law

John D. Blum & Jordan Paradise, Public Health Preparedness & Response: An Exercise in Administrative Law, 20 DEPAUL J. HEALTH CARE L. 1, 2019
Number of pages: 23 Posted: 10 Mar 2020
John D. Blum and Jordan Paradise
Loyola University of Chicago Law School and Loyola University Chicago School of Law
Downloads 40 (507,637)

Abstract:

Loading...

31.

Case Note: Sandoz v. Amgen

Jordan Paradise, Case Note: Sandoz v. Amgen, FDLI Update p. 32 (July/August 2017)
Number of pages: 3 Posted: 07 Aug 2017 Last Revised: 01 Mar 2018
Jordan Paradise
Loyola University Chicago School of Law
Downloads 39 (501,703)

Abstract:

Loading...

32.

Regulatory Silence at the FDA: Impact on Access and Innovation

Minnesota Law Review, Vol. 102, 2018
Number of pages: 28 Posted: 21 Aug 2017 Last Revised: 01 Mar 2018
Jordan Paradise
Loyola University Chicago School of Law
Downloads 29 (552,374)

Abstract:

Loading...

33.

Three Framings of 'Faster' at the FDA and the Federal Right to Try

Jordan Paradise, Three Framings of "Faster" at the FDA and the Federal Right to Try, 11 Wake Forest Journal of Law & Policy 53 (2020).
Number of pages: 32 Posted: 08 Jun 2020 Last Revised: 27 Jan 2021
Jordan Paradise
Loyola University Chicago School of Law
Downloads 22 (595,958)

Abstract:

Loading...

34.

Decoding the Research Exemption

Nature Reviews Genetics, Vol. 7, No. 2, pp. 148-154, 2006
Number of pages: 7 Posted: 25 May 2006 Last Revised: 17 Aug 2017
Jordan Paradise and Christopher Janson
Loyola University Chicago School of Law and NEAR
Downloads 21 (602,631)

Abstract:

Loading...

genetics, research, patents, research exemption, international

35.

Patient Advocacy Group Collaboration in Genetic Research and the Scope of 'Joint Inventorship' Under U.S. Patent Law

International Journal of Intellectual Property Management, Vol. 3, No. 2, pp. 97-109, 2009
Number of pages: 13 Posted: 28 Jul 2009 Last Revised: 28 Feb 2018
Jordan Paradise
Loyola University Chicago School of Law
Downloads 17 (629,627)

Abstract:

Loading...

36.

Regulatory Frameworks for Precision Medicine at the Food & Drug Administration

Jordan Paradise, Regulatory Frameworks for Precision Medicine at the Food & Drug Administration, 15(1) SciTech Lawyer 12 (2018).
Number of pages: 6 Posted: 08 Jun 2020
Jordan Paradise
Loyola University Chicago School of Law
Downloads 12 (665,536)

Abstract:

Loading...

37.

COVID-IP: Staring Down the Bayh-Dole Act with 2020 Vision

Jordan Paradise, COVID-IP: Staring Down the Bayh-Dole Act with 2020 Vision, 7 Journal of Law & the Biosciences 1 (2020).
Number of pages: 13 Posted: 13 May 2020 Last Revised: 27 Jan 2021
Jordan Paradise
Loyola University Chicago School of Law
Downloads 11 (672,865)

Abstract:

Loading...

38.

Electronic Cigarettes: Smoke-Free Laws, Use Restrictions, and the Public Health

104 Am. J. Pub. Health e17 (2014)
Number of pages: 2 Posted: 21 Aug 2017
Jordan Paradise
Loyola University Chicago School of Law
Downloads 8 (694,895)

Abstract:

Loading...

electronic cigarettes, FDA, state laws, smoke-free, health, safety

Other Papers (5)

Total Downloads: 41
Actions:
Email selected abstracts
1.

States Tackle Biosimilar Substitution

Health Reform Watch, March 2014
Number of pages: 3 Posted: 03 Apr 2014
Jordan Paradise
Loyola University Chicago School of Law
Downloads 23

Abstract:

Loading...

FDA, biosimilar, interchangeable, state laws, substitution

2.

The Trans Fat Smackdown

Health Reform Watch, November 2013
Number of pages: 2 Posted: 03 Apr 2014
Jordan Paradise
Loyola University Chicago School of Law
Downloads 7

Abstract:

Loading...

FDA, trans fat, regulations

3.

Funding, and Ethics, for the BRAIN Initiative

Health Reform Watch, October 2013
Number of pages: 2 Posted: 03 Apr 2014
Jordan Paradise
Loyola University Chicago School of Law
Downloads 6

Abstract:

Loading...

BRAIN initiative, bioethics, federal funding, neuroscience, law

4.

FDA's Proposed Changes to Generic Drug Label Rules Questioned by Members of Congress

Health Reform Watch, January 2014
Number of pages: 2 Posted: 03 Apr 2014
Jordan Paradise
Loyola University Chicago School of Law
Downloads 4

Abstract:

Loading...

generic drugs, labeling, proposed regulation, FDA, Supreme Court

5.

FDA Taking Baby Steps Toward Regulating Nanotechnology

Health Reform Watch, June 2011
Number of pages: 4 Posted: 04 Apr 2014
Jordan Paradise
Loyola University Chicago School of Law
Downloads 1

Abstract:

Loading...

FDA, nanotechnology, drug, biologic, device